DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Medrylamine

Medrylamine

  • Prohibited Substances List

    Prohibited Substances List

  • (12) Patent Application Publication (10) Pub. No.: US 2010/0081713 A1 Sharma Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2010/0081713 A1 Sharma Et Al

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • (19) 11 Patent Number: 6165500

    (19) 11 Patent Number: 6165500

  • Proposed Changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (Effective from 01.01.2022)

    Proposed Changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (Effective from 01.01.2022)

  • The Organic Chemistry of Drug Synthesis

    The Organic Chemistry of Drug Synthesis

  • Departamento De Química - Física

    Departamento De Química - Física

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Wo 2008/127291 A2

    Wo 2008/127291 A2

  • Dimethylethanolamine (DMAE) [108-01-0] and Selected Salts

    Dimethylethanolamine (DMAE) [108-01-0] and Selected Salts

  • (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • Elective Testing Substances List

    Elective Testing Substances List

  • Ep 2301628 A1

    Ep 2301628 A1

  • FEI Prohibited Substances List

    FEI Prohibited Substances List

  • (12) United States Patent (10) Patent No.: US 9,682,043 B2 Goldman (45) Date of Patent: Jun

    (12) United States Patent (10) Patent No.: US 9,682,043 B2 Goldman (45) Date of Patent: Jun

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • ROSE PHARMACY GPAT Time: 3 Hours (Subject:- ANS, CNS & CVS)

    ROSE PHARMACY GPAT Time: 3 Hours (Subject:- ANS, CNS & CVS)

Top View
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • FEI Prohibited Substances List
  • Birla Institute of Technology & Science-Pilani, Hyderabad
  • Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
  • Final20october2009versionoflist 13 November 2009
  • Customs Tariff - Schedule
  • 2019 Equine Prohibited Substances List
  • (12) United States Patent (10) Patent No.: US 7,906,140 B2 Bromley Et Al
  • Pharmaabkommen A1 E
  • FEI EPSL Controlled Medication, 30 November 2018
  • FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • Customs Tariff - Schedule Xxi - 1
  • Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
  • (12) United States Patent (10) Patent No.: US 8,703,823 B2 Salehani (45) Date of Patent: Apr
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • Histamine H1-Receptor Antagonists: Antihistaminic Agents


© 2024 Docslib.org    Feedback